A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017) von Decroisette, C, Monnet, I., Ricordel, C, Demaegdt, A., Falchero, L, Bylicki, O., Geier, M., Justeaux, G., Bernardi, M., Andre, M., Guisier, F., Fournel, P, Vieillot, S., Hauss, P.-A., Schott, R, Crequit, J., Auliac, J. B., Chouaid, C, Greillier, L

Volltext

1035P A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-... von Decroisette, C., Monnet, I., Ricordel, C., Demaegdt, A., Falchero, L., Bylicki, O., Geier, M., Justeaux, G., Bernardi, M., Andre, M., Guisier, F., Fournel, P., Vieillot, S., Hauss, P.A., Schott, R., Crequit, J., Auliac, J.B., Chouaid, C., Greillier, L.

Volltext